These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1253160

  • 1. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
    Heppner GH, Kopp JS, Medina D.
    Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
    [Abstract] [Full Text] [Related]

  • 2. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
    Wei WZ, Ficsor-Jacobs R, Tsai SJ, Pauley R.
    Cancer Res; 1991 Jun 15; 51(12):3331-3. PubMed ID: 2040009
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of keratin expression in mouse mammary hyperplastic alveolar nodules and adenocarcinomas.
    Asch HL, Asch BB.
    Cancer Res; 1985 Jun 15; 45(6):2760-8. PubMed ID: 2580627
    [Abstract] [Full Text] [Related]

  • 4. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice.
    DeOme KB, Miyamoto MJ, Osborn RC, Guzman RC, Lum K.
    Cancer Res; 1978 Jul 15; 38(7):2103-11. PubMed ID: 207423
    [Abstract] [Full Text] [Related]

  • 5. Opposing effects of cryostat sections of preneoplastic and neoplastic mouse mammary lesions on in vitro migration of peritoneal exudate cells.
    Wei WZ, Miller FR, Blazar BA, Medina D, Heppner G.
    J Immunol; 1979 May 15; 122(5):2059-67. PubMed ID: 448117
    [Abstract] [Full Text] [Related]

  • 6. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS.
    Cancer Res; 1993 Jul 15; 53(14):3374-81. PubMed ID: 8324748
    [Abstract] [Full Text] [Related]

  • 7. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL, Lanford RE, Medina D, Butel JS.
    Cancer Res; 1984 May 15; 44(5):2155-62. PubMed ID: 6324998
    [Abstract] [Full Text] [Related]

  • 8. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
    Smith GH, Vonderhaar BK, Graham DE, Medina D.
    Cancer Res; 1984 Aug 15; 44(8):3426-37. PubMed ID: 6430550
    [Abstract] [Full Text] [Related]

  • 9. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
    Tsai SJ, Loeffler DA, Heppner GH.
    Cancer Res; 1992 Apr 15; 52(8):2209-15. PubMed ID: 1559224
    [Abstract] [Full Text] [Related]

  • 10. Distinction between preneopastic and neoplastic mammary cell populations in vitro by cytochalasin B-induced multinucleation.
    Medina D, Oborn CJ, Asch BB.
    Cancer Res; 1980 Feb 15; 40(2):329-33. PubMed ID: 7356516
    [Abstract] [Full Text] [Related]

  • 11. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
    Wei WZ, Wang H, Ficsor-Jacobs R, Pauley R.
    Cancer Res; 1992 Oct 01; 52(19):5183-9. PubMed ID: 1327503
    [Abstract] [Full Text] [Related]

  • 12. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion.
    Wei WZ, Fulton A, Winkelhake J, Heppner G.
    Cancer Res; 1989 May 15; 49(10):2709-15. PubMed ID: 2785436
    [Abstract] [Full Text] [Related]

  • 13. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B, Blazar B, Medina D, Heppner G.
    J Immunol; 1979 Jun 15; 122(6):2180-3. PubMed ID: 448122
    [Abstract] [Full Text] [Related]

  • 14. Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors.
    Medina D, Iramain CA, Clark JH.
    Cancer Res; 1975 Sep 15; 35(9):2355-69. PubMed ID: 167955
    [Abstract] [Full Text] [Related]

  • 15. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun 15; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 16. Preferential growth of mammary tumors in intact mammary fatpads.
    Miller FR, Medina D, Heppner GH.
    Cancer Res; 1981 Oct 15; 41(10):3863-7. PubMed ID: 7284994
    [Abstract] [Full Text] [Related]

  • 17. A high-tumor-incidence subline of the D1 mouse mammary hyperplastic outgrowth line: effect of carcinogens.
    Ashley RL, Cardiff RD, Pratt TS, Faulkin LJ.
    J Natl Cancer Inst; 1982 Sep 15; 69(3):639-45. PubMed ID: 6287083
    [Abstract] [Full Text] [Related]

  • 18. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    Blazar BA, Miller FR, Heppner GH.
    J Immunol; 1978 Jun 15; 120(6):1887-91. PubMed ID: 659883
    [Abstract] [Full Text] [Related]

  • 19. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA, Hellström I.
    J Immunol; 1975 Mar 15; 114(3):1083-8. PubMed ID: 1112984
    [Abstract] [Full Text] [Related]

  • 20. Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation.
    Gimbrone MA, Gullino PM.
    Cancer Res; 1976 Jul 15; 36(7 PT 2):2611-20. PubMed ID: 1277168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.